These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 31519432

  • 21. A Parsimonious Prognostic Model and Heat Map for Predicting Survival Following Adjuvant Radiotherapy in Parotid Gland Carcinoma With Lymph Node Metastasis.
    Jiang WM, Wu LL, Wei HY, Ma QL, Zhang Q.
    Technol Cancer Res Treat; 2021; 20():15330338211035257. PubMed ID: 34342241
    [Abstract] [Full Text] [Related]

  • 22. Effect of margin status and pathological grade in treatment of sinonasal mucoepidermoid carcinoma.
    Auger SR, Patel T, Ganti A, Raman A, Shay A, Kuhar HN, Kuan EC, Papagiannopoulos P, Batra PS, Tajudeen BA.
    Laryngoscope; 2020 Dec; 130(12):E750-E757. PubMed ID: 31913506
    [Abstract] [Full Text] [Related]

  • 23. Survival Impact of Elective Neck Dissection and Adjuvant Radiation in N0 High-Grade Mucoepidermoid Carcinoma.
    Panara K, Sangal N, Lakshmipathy D, Rajasekaran K.
    Otolaryngol Head Neck Surg; 2024 Jul; 171(1):138-145. PubMed ID: 38426623
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Surgical extent and role of adjuvant radiotherapy of surgically resectable, low-grade parotid cancer.
    Park YM, Kang MS, Kim DH, Koh YW, Kim SH, Lim JY, Choi EC.
    Oral Oncol; 2020 Aug; 107():104780. PubMed ID: 32442895
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Mucoepidermoid carcinoma of the parotid gland: Twenty-year experience in treatment and outcomes.
    Chan SA, Van Abel KM, Lewis JE, Routman DM, Garcia JJ, Karp EE, Price DL, Janus JR, Kasperbauer JL, Moore EJ.
    Head Neck; 2021 Sep; 43(9):2663-2671. PubMed ID: 33931913
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Clinicopathologic features as stronger prognostic factors than histology or grade in risk stratification of primary parotid malignancies.
    Walvekar RR, Filho PAA, Seethala RR, Gooding WE, Heron DE, Johnson JT, Ferris RL.
    Head Neck; 2011 Feb; 33(2):225-231. PubMed ID: 21298822
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Pediatric Salivary Cancer: Epidemiology, Treatment Trends, and Association of Treatment Modality with Survival.
    Morse E, Fujiwara RJT, Husain Z, Judson B, Mehra S.
    Otolaryngol Head Neck Surg; 2018 Sep; 159(3):553-563. PubMed ID: 29688836
    [Abstract] [Full Text] [Related]

  • 40. Prognostic Factors and Treatment Outcomes of Parotid Gland Cancer: A 10-Year Single-Center Experience.
    Chang JW, Hong HJ, Ban MJ, Shin YS, Kim WS, Koh YW, Choi EC.
    Otolaryngol Head Neck Surg; 2015 Dec; 153(6):981-9. PubMed ID: 26203086
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.